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Abstract 
Purpose: To evaluate the anti-diabetic potential of methanol extract of the aerial parts of Galium 
tricornutum (Dandy) in diabetic rats.  
Methods: The methanol extract of the aerial parts of Galium tricornutum was first subjected to acute 
toxicity studies. Thereafter, the effect of the extract on oral glucose tolerance was determined. In 
addition, the effect of the extract on fasting blood glucose, as well as serum lipid profile, urea, 
creatinine, alanine transaminase (ALT), aspartate transaminase (AST), bilirubin, alkaline phosphatase 
(ALP) and protein were investigated in alloxan-induced diabetic rats. 
Results: No acute toxicity were observed in the rats after administration of the plant extract up to a 
dose of 2000 mg/kg.  The effect of the extract on glucose tolerance test was significant from 30 to 180 
min after treatment. In the diabetic rats, the extract showed significant (p < 0.05) anti-hyperglycemic 
activity at 400 mg/kg. It also led to significant increases in body weight and HDL-cholesterol, and 
significant reductions in serum LDL, triglycerides and transaminases (p < 0.05).  
Conclusion: These results indicate that the aerial parts of G. tricornutum possess significant anti-
diabetic potential. 
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Diabetes mellitus is one of the most common 
metabolic disorders. It is caused by inability of 
pancreatic cells to produce insulin, or defects in 
insulin utilization. The disease is associated with 
significant morbidity and mortality, and is 
considered one of the five leading causes of 
death in the world [1]. There are no drugs that 
can effectively treat diabetes mellitus. Moreover, 
the use hypoglycemic drugs and insulin results in 
unwanted side effects. Thus there is increasing 
interest in the management of diabetes through 
the use of natural products with hypoglycemic 
potential.  
 
Many medicinal plants have been reported to 
possess hypoglycemic properties. These include 
Ocimum santum (Tulsi), Momordica charantia 
(bitter round), Trigonella foenum (Fenugreek), 
Allium sativum (garlic), Vinca rosea (nayantara), 
and Azadirachta indica (neem).  However, in 
severe diabetes, many of these plants are not 
very effective in lowering blood glucose levels.  
 
Galium tricornutum is an annual herb that 
belongs to the family Rubiaceae. It has trailing or 
climbing stems and is found almost all over the 
world. The plant is used as an anti-scorbutic 
agent, and as a refrigerant, diuretic and aperient 
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[2]. It is also used as anti-malarial, antipyretic 
and emetic [3]. In the northern parts of Pakistan, 
the plant is used for the treatment of skin 
infections [4]. However, despite its medicinal 
importance, no studies have been carried out on 
the anti-diabetic potential of Galium tricornutum 
to date. 
 
The present study was carried out to investigate 
the anti-diabetic effects of methanol extract of 
aerial parts of Galium tricornutum in alloxan-
induced diabetic rats. Antidiabetic potential and 
biochemical parameters such as LDL, HDL, 
cholesterol, urea, creatinine, ALP, bilirubin, 
triglycerides, protein, ALT and SPT were studied 
in male Wistar albino rats exposed to two doses 




Plant collection and extraction 
 
Galium tricornutum was collected from the 
outskirts of Bannu district, Khyber Pakhtunkhwa, 
Pakistan. The plant was identified and 
authenticated by Professor Abdur Rahman, 
Department of Botany, Government 
Postgraduate College, Bannu.  
 
The aerial parts of the plant were shade-dried, 
and made into coarse powder by pulverization. 
The coarse powder (200 g) put extracted by 
shaking with 80 % commercial grade methanol in 
a beaker for 3 days, and the extract was filtered 




Wistar albino rats of both sexes (8 - 10 weeks 
old) weighing 170 – 200 g were obtained from 
the Animal House of Quaid-i-Azam University, 
Islamabad. The rats were fed with standard rat 
feed before and during the experiment, and were 
randomly assigned to various groups. Prior to 
commencement of the study, the rats were 
acclimatized to laboratory conditions for 7 days 
at room temperature, 12 hour-dark/light cycle 
and relative humidity. 
 
Acute oral toxicity studies  
 
The experiment was conducted according to the 
guide lines for experimental animal model [5] 
approved by the ethical committee of University 
of Science and Technology Bannu. Two groups 
of rats (3 rats/group) were treated orally with the 
Galium tricornutum extract at a dose of 5000 
mg/kg. A third group received an equivalent 
volume of normal saline. The dose of 5000 
mg/kg did not result in mortality or any signs of 
toxicity or changes in general behavior. 
 
Oral glucose tolerance test  
 
Four groups of rats (6 rats/group) were used. 
The rats were fasted for 16 hr before the test. 
Group I served as normal control and received 
normal saline p.o. only. Group II received 
glucose (3 g/kg) only. Groups III and IV received 
methanol extract at 200 mg/kg and 400 mg/kg, 
respectively. Thirty minutes after extract 
administration, rats in groups III and IV were 
given glucose (3 mg/kg, p.o.). Blood samples 
were collected from the retro-orbital plexus just 
prior to extract administration, and 30, 90 and 
150 min after glucose load, for measurement of 
serum glucose levels  using ACCU-
CHEK® Active meter (Indianapolis, USA). 
 
Effect of extract on alloxan-induced diabetes 
in rats  
 
The rats were divided into five groups, each with 
six rats, and were treated as summarized below: 
 
Group I: Normal control (saline). 
 
Group II: Alloxan-treated control (150 mg/kg.ip). 
 
Group III: Alloxan (150 mg/kg. i.p.) + Galium 
tricornutum extract (200 mg/kg, p.o.). 
 
Group IV: Alloxan (150 mg/kg. i.p.) + Galium 
tricornutum extract (400mg/kg, p.o.). 
 
Group V: Alloxan (150 mg/kg.ip) + Standard 
drug, glibenclamide (5mg/kg, p.o.). 
 
All treatments lasted for 21 consecutive days. 
The extract, standard drug glibenclamide (5 
mg/kg) and saline were administered via a 
feeding cannula.  
 
Induction of diabetes in experimental animals 
 
Diabetes was inducted in the experimental 
animals by a single intraperitoneal (i.p.) dose of 
alloxan monohydrate (150 mg/kg). Alloxan was 
dissolved in normal saline prior to administration. 
Since alloxan causes fatal hypoglycemia 
because of massive release of insulin, the rats 
were given 20 % glucose solution i.p. after 6 
hours. In addition, 5 % glucose solution bottles 
were kept handy for 24 hr to prevent 
hypoglycemia [5]. After 48 hours of alloxan 
injection, rats with blood glucose levels less than 
200 mg/dL were included in the study. Treatment 
with extract and glibenclamide was started 48 h 
after alloxan injection. 
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Collection of blood samples and blood 
glucose determination  
 
Blood samples were taken from tail tip of the 
rats. Estimations of fasting blood glucose and 
body weight measurement were done onset, and 
on the 1st, 7th, 14th and 21st days of the study. 
Blood glucose levels were checked by one-touch 
electronic glucometer using glucose test strips. 
On day 21, fasting blood glucose was estimated 
in overnight-fasted rats, with blood taken from 
the retro-orbital plexus under mild ether 
anesthesia [6]. Serum was separated and 
analyzed for LDL [7] and HDL [8] cholesterol, as 
well as triglycerides [9], urea [10], creatinine [11], 





Data were expressed as mean ± SEM. 
Differences between groups were assessed by 
one-way analysis of variance (ANOVA) using the 
Statistical Package for Social Sciences (SPSS) 
software package for Windows (version 13.0). 
Post hoc testing was performed for inter-group 
comparisons using the least significant difference 





Acute oral toxicity  
 
The OECD guidelines AOT-425 was used for 
determination of acute toxicity of the extract in 
rats. A single oral dose of Galium tricornutum 
(5000 mg/kg) did not cause any signs of toxicity 
or mortality in the rats within 4 hrs. The animals 
were observed continuously and were found to 
be safe at a dose of up to 5000 mg/kg. 
 
Oral glucose tolerance test 
 
The effects of methanol extracts of Galium 
tricornutum (200 and 400 mg/kg) on oral glucose 
tolerance test are shown in Table 1. The extract 
improved glucose tolerance in fasted normal rats, 
with significant decreases in serum glucose 
levels at 90 minutes and at 150 minutes post-
glucose load. 
 
Effect of G. tricornutum on fasting blood 
glucose levels of alloxan-diabetic rats 
 
The anti-diabetic effect of Galium tricornutum 
on the fasting blood glucose levels of diabetic 
rats is shown in Table 2. Administration of 
alloxan (150 mg/kg, i.p.) led to increases in 
fasting blood glucose levels, which were 
maintained over a period of three weeks. 
However, daily administration of G. tricornutum 
extract for 3 weeks led to dose-dependent 
decreases in blood glucose levels. The 
decreases in blood glucose peaked on day 21 of 
treatment. Rats in normal control showed slight 
increases in body weight but the body weights of 
the diabetic rats were significantly decreased 
during the 21–day study period. 
 
Effect of G. tricornutum extract on body 
weight and on some serum, biochemical 
indices in alloxan-diabetic rats 
 
Alloxan caused decreases in body weight, which 
were reversed by the extract (400 mg/kg and 200 
mg/kg) after 21 days of treatment (Table 3). It 
also bought about significant increases in serum 
cholesterol, LDL, creatinine, urea and ALP; and 




       Table 1: Changes in serum glucose in the glucose tolerance test (mg/dL) 
 
Group 0 min 30 min 90 min 150 min 
Normal 69.5±2.2  68.5±5.4 71±5.1 69.3±4.1 
Glucose (3g/kg) 69.3±5.4 110.1±4.7 121.3±4.3 129.6±4.5 
Glucose (3mg/kg) + 200mg/kg G. 
tricornutum 
70.6±4.6 100±4.9 93.8±3.7 89.1±5.1 
Glucose (3g/kg) + 400mg/kg G. 
tricornutum 
70.3±5.4 95.3±4.7 89.3±2.9 84.6±2.7 
 
Table 2: Effect of extract on fasting blood glucose levels of alloxan-diabetic rats (mg/dL) 
 
Group Initial 1st day 7th day 14th day 21st day 
Normal 70.66±2.6 70.16±2.8 70±2.4 70±3.5 72.83±4.1 
Diabetic control 222.6±3.1 222.5±7.1 240±2.4 246.16±3.1 260.16±3.7 
Diabetic + 200m/k G. tricornutum 261.3±2.8 248.6±6.1 206.16±1.8 148.5±4.0 130.5±3.1 
Diabetic + 400m/kg G. tricornutum 257.6±3.0 246.5±5.6 190.3±3.8 144.83±2.5 123.16±3.2 
Diabetic + glibenclamide 249.8±7.1 189.16±3.8 140.3±4.0 88.5±3.1 69.66±2.6 
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       Table 3: Effect of extract on body weight of rats (grams) 
 
Group Day 1 Day 7 Day 14 Day 21 
Normal 170±2.5 174.6±5.0 176±2.7 178.6±3.8 
Diabetic control 181.8±3.8 177.6±4.7 169.8±3.1 161±4.3 
Diabetic+200mg/kg extract 170±2.4 165.3±5.2 160.3±4.7 157±5.1 
Diabetic+400mg/kg extract 170±3.1 168±6.0 163±3.2 160±3.1 
Diabetic + glibenclamide 175.8±5.0 174.5±2.4 175.8±2.9 173.3±2.8 
 













(mg/dl )  
Bilirubin 
(mg/dl )  
TG 
(mg/dl )  
Protein 
(g/dl )  
ALT 
(U/l) 
Normal 93±4.6 37±1.8 155±5.1 25±1.0 0.71±0.01 128±4.1 0.73±0.1 95±5.4 6.7±0.4 49±1.4 
Diabetic 
control 








99.8±5.0 33.6±2.0 170±3.1 33.6±2.3 0.60±0.3 129.6±4.5 0.62±0.1 144.8±3.8 5.23±0.1 67.8±3.4 
Diabetic + 
glibenclamide 
91.8±3.7 35.5±1.7 147±2.4 30±1.2 0.57±0.2 121.8±2.5 0.59±0.2 125±3.9 6.34±0.5 58.6±2.7 
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Similarly, serum levels of other biochemical 
parameters (bilirubin, triglycerides, ALT and 
AST) were significantly increased, while total 
protein was significantly decreased by alloxan (p 
˂ 0.05). These alloxan-induced changes were 





The management of diabetes mellitus is faced 
with the major challenge of finding antidiabetic 
agents without side effects.  This has led to 
increased interest in natural products with anti-
hyperglycemic potential, which have the 
advantage of producing much less side effects 
when compared with orthodox hypoglycemic 
drugs. Alloxan exerts its effect by destroying 
insulin-producing beta cells of the pancreas [16]. 
In vitro studies have revealed that alloxan is 
selectively toxic to beta cells of pancreas and 
can induce cell necrosis [17]. The cytotoxic effect 
of alloxan is mediated by ROS, which increase 
cytosolic calcium concentrations, leading to 
destruction of beta cells of pancreas [18]. Many 
plant extracts exert anti-diabetic effects by 
promoting beta cells regeneration or by 
protecting these cells from destruction, through 
enhancement of unrestricted endogenous insulin 
action. Plant extracts may also induce release of 
insulin by beta cells, or activate insulin receptors 
[19].  
 
Results from the present study showed that oral 
administration of G. tricornutum extract (400 
mg/kg) for 21 days produced significant 
improvements in alloxan-induced diabetes and 
glucose tolerance test in rats. These effects are 
evident from results obtained in assays of LDL, 
HDL, cholesterol, urea, creatinine, ALP, bilirubin, 
triglyceride, protein, ALT and AST. Interestingly, 
the anti-diabetic effect of the extract was 
comparable to that of glibenclamide, a standard 
hypoglycemic agent. In addition, the anti-diabetic 
effect of the extract was higher at a dose of 400 
mg/kg than at the lower dose of 200 mg/kg. Thus 
the observed anti-diabetic potential was dose-
dependent. These results indicate that G. 
tricornutum has very good anti-diabetic 
properties. It has been established that the 
antioxidant properties of plant extracts are due to 
the presence of flavonoids and tannins [20]. 
Preliminary phytochemical screening of the G. 
tricornutum extract also revealed the presence of 
flavonoids and tannins. Thus these components 
are likely to be responsible for the observed anti-




The results obtained in this study indicate that 
methanol extract of G. tricornutum possesses 
significant anti-diabetic effects. This finding is 
considered useful for the development of new 
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